The European Commission says it has made “good progress” on resolving concerns raised by regulatory authorities participating in the international Pharmaceutical Inspection Co-operation Scheme (PIC/S), and some other stakeholders, about its draft guideline on good manufacturing practice requirements for advanced therapy medicinal products (ATMPs).
The guideline – which is eagerly awaited by the pharmaceutical industry – was initially due to be finalized on April...